• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Microneedles for therapeutic gene delivery

Bioengineer by Bioengineer
October 7, 2020
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers develop a minimally invasive biodegradable microneedle patch as a novel delivery mode for gene therapy applications

IMAGE

Credit: Khademhosseini Lab

(LOS ANGELES) – There is great potential in gene therapy for treating certain types of cancer and genetic defects, immunological diseases, wounds and infections. The therapies work by delivering genes into the patients’ cells, which then produce therapeutic proteins to treat the affliction.

When determining the method of delivery for these genes, there are advantages to choosing a local, rather than systemic delivery of the genetic material. With systemic delivery, there is the possibility of unwanted tissue accumulation or of the genetic material becoming unstable. It is also advantageous to target the skin as a site for local delivery, as it is easily accessible and contains fluid and lymph vessels, as well as immune cells upon which the genetic material can act to initiate treatment.

Despite these advantages, it is still difficult to deliver genes into the skin. An ideal gene delivery approach must be able to deliver the genetic material without producing inflammation or toxicity in the body and should be able to penetrate the skin layer effectively.

A collaborative team, which includes a group from the Terasaki Institute for Biomedical Innovation, has recently published an approach based on microneedles that meets these challenges. These microneedles are made of a biocompatible material mixed with nanoparticles containing therapeutic genes. This mixture can be molded into a microneedle patch array for application to the skin. The microneedles are biodegradable, so once they have penetrated the skin, they will release the nanoparticles upon needle degradation. Moreover, the timing and sustainability of this release can be controlled by adjustments in the biomaterial preparation.

The team conducted extensive tests to optimize the release and performance of the gene-containing nanoparticles, and they also validated the efficacy of the genes. “This biodegradable microneedle patch with gene-delivering nanoparticles is an effective and minimally-invasive vehicle for local therapeutic gene delivery,” said Terasaki Institute Fellow Wujin Sun, Ph.D., who is an author of the publication. “This platform can be utilized for applications such as vaccinations, protein supplementation or gene editing.”

The development of these microneedles illustrates the potential for similar gene delivery systems that can be customized according to the therapeutic genes chosen. This new technology can provide a more effective way to treat skin and other cancers, skin-related cosmetic needs or diseases such as psoriasis and muscular dystrophy. It can even be used as a method for vaccine delivery against such diseases as skin or breast cancer, influenza or COVID-19.

“The ability to enable local therapeutic gene delivery using this microneedle system is a notable achievement,” said Terasaki Institute Director and CEO Ali Khademhosseini, Ph.D., who is the senior author of the paper. “It opens the possibilities for a variety of clinical applications and synergizes with a number of platforms at the Terasaki Institute, which aims to leverage our ability to find personalized solutions for patients.

###

Additional authors are Moyuan Qu, HanJun Kim, Xingwu Zhou, Canran Wang, Xing Jiang, Jixiang Zhu, Yumeng Xue, Peyton Tebon, Shima A. Sarabi, Samad Ahadian, Mehmet R. Dockmeci, Songsong Zhu, and Zhen Gu.

Financial support came from the National Institutes of Health (GM126831).

PRESS CONTACT

Stewart Han, [email protected], +1 818-836-4393
Terasaki Institute for Biomedical Innovation

The Terasaki Institute for Biomedical Innovation (terasaki.org) is a non-profit research organization that invents and fosters practical solutions that restore or enhance the health of individuals. Research at the Terasaki Institute leverages scientific advancements that enable an understanding of what makes each person unique, from the macroscale of human tissues down to the microscale of genes, to create technological solutions for some of the most pressing medical problems of our time. We use innovative technology platforms to study human disease on the level of individual patients by incorporating advanced computational and tissue-engineering methods. Findings yielded by these studies are translated by our research teams into tailored diagnostic and therapeutic approaches encompassing personalized materials, cells, and implants with unique potential and broad applicability to a variety of diseases, disorders, and injuries.

The Institute is made possible through an endowment from the late Dr. Paul I. Terasaki, a pioneer in the field of organ transplant technology.

Media Contact
Stewart Han
[email protected]

Original Source

https://terasaki.org/institute/news/pr/microneedles.html

Related Journal Article

http://dx.doi.org/10.1039/D0NR02759F

Tags: Biomedical/Environmental/Chemical EngineeringBiotechnologyGene TherapyGeneticsHealth CareMedicine/HealthNanotechnology/MicromachinesResearch/Development
Share12Tweet8Share2ShareShareShare2

Related Posts

Bioactive Compounds from Paenibacillus Dendritiformis Show Antibacterial Effects

Bioactive Compounds from Paenibacillus Dendritiformis Show Antibacterial Effects

August 5, 2025
blank

New Salmonella Vaccine Targets Coccidiosis in Poultry

August 5, 2025

Beeswax-Taro Starch Bigels: Ratio Impacts Structure

August 5, 2025

Lycii Fructus Extracts and Zeaxanthin Inhibit Osteoclasts

August 5, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Neuropsychiatric Risks Linked to COVID-19 Revealed

    71 shares
    Share 28 Tweet 18
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    46 shares
    Share 18 Tweet 12
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Diastereodivergent Routes to Multi-Substituted Cycloalkanes

Spatial Metabolomics Reveals Lasting Stroke Brain Changes

Rethinking Resilience in Post-Nuclear Food Trade Recovery

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.